Using ultrasound to guide brain surgery for tumors and lesions

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to evaluate the effectiveness of intraoperative sonography in detecting various brain mass lesions, such as tumors and vascular malformations, during surgery. The approach involves using ultrasound to assess the extent of lesion resection in real-time, which can enhance surgical precision. The study will utilize novel techniques, including ultrasound-guided needles and ports, to facilitate access to challenging lesions. By integrating ultrasound into the surgical workflow, the study seeks to improve outcomes for patients undergoing brain surgery.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* meningioma
* glioma
* cerebral metastasis of solid tumors of any primary origin
* supratentorial localization
* age 18-80 years
* intraoperative use of sonography.

Exclusion Criteria:

* history of brain tumor radiotherapy (except for a single-session stereotactic radiosurgery performed no earlier than 7 days prior to surgery)
* anatomical features of the surgical approach that preclude correct positioning of the ultrasound transducer within the operative wound.

Where it's running

• Sklifosovsky Institute of Emergency Care
  Moscow, Russia Recruiting

Study contacts

• Principal investigator: Alexander Dmitriev, MD — Sklifosovsky Institute of Emergency Care
• Study coordinator: Alexander Dmitriev, MD
• Email: dmitriev@neurosklif.ru
• Phone: +7 (916) 423-54-08

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Calculating brain shift during surgery

  This study is testing a new way to track changes in the brain during surgery to see if it can help doctors perform better and improve results for patients with brain tumors and other brain issues.

  Recruiting Sklifosovsky Institute of Emergency Care · Moscow · NCT05477680

• YN003 injection in glioma patients

  This phase 1 study tests whether YN003 injected IV is safe and tolerable for adults with recurrent or progressive glioma, and to explore how the drug behaves in the body and any early signs of activity.

  Recruiting at 2 sites Phase 1 Beijing Inno Medicine Co., Ltd. · Los Angeles, California and 4 other locations · NCT07929909

• Brain connectome project in adults with brain glioma undergoing surgery

  This registry collects MRI data and clinical information from adults with glioma to see how brain networks relate to surgery and recovery.

  Recruiting Northwell Health · New York, New York · NCT07927595

• Proton vs. Photon Radiation for Certain Grade 2–3 Gliomas

  This study tests whether proton therapy can better preserve thinking and memory than photon therapy for adults with IDH-mutated grade 2–3 gliomas who need radiation.

  Recruiting at 2 sites University Hospital, Essen · Essen and 1 other locations · NCT07750457

• Connectome-guided network planning for brain tumor surgery in eloquent areas

  This study tests whether using patient-specific brain network maps from diffusion MRI can help surgeons plan and guide brain tumor removal in eloquent areas.

  Recruiting ARNAS Civico Di Cristina Benfratelli Hospital · Palermo, PA · NCT07717827

• AI-powered analysis of brain MRI to help glioma care

  Doctors will use AI to study existing MRI scans and patient data from adults with glioma to see if it can help with non-invasive diagnosis and treatment planning.

  Recruiting Università degli Studi di Trento · Trento · NCT07703761

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.